Bioxytran和明尼苏达大学发起了一项研究伙伴关系,利用先进的NMR技术研究碳水化合物治疗方法,研究结果支持Bioxytran在遗传学、缺氧和退化性疾病方面的工作。 Bioxytran and the University of Minnesota launch a research partnership to study carbohydrate therapeutics using advanced NMR techniques, with findings supporting Bioxytran’s work in glycovirology, hypoxia, and degenerative diseases.

Bioxytran公司与明尼苏达大学发起了一项多年期研究协作,在2027年初提供资金,研究碳水化合物治疗方法。 Bioxytran, Inc. has launched a multi-year research collaboration with the University of Minnesota, funded through early 2027, to study carbohydrate-based therapeutics. 该项目由Kevin Mayo博士牵头,使用先进的NMR技术分析聚沙英和寡头沙英如何与生物目标相互作用,重点是绑定性、结构性和亲近性。 Led by Dr. Kevin Mayo, the project uses advanced NMR techniques to analyze how polysaccharides and oligosaccharides interact with biological targets, focusing on binding, structure, and affinity. 这项研究旨在支持Bioxytran在遗传病、缺氧和退化性疾病方面的工作。 The research aims to support Bioxytran’s work in glycovirology, hypoxia, and degenerative diseases. 大学将根据学术标准开展工作,保留知识产权所有权,而Bioxytran公司将获得将研究结果用于内部发展的广泛权利。 The University will conduct the work under academic standards, retain IP ownership, while Bioxytran gains broad rights to use findings for internal development. 这一伙伴关系反映出工业-学术界为推动生物医学而日益努力。 The partnership reflects growing industry-academia efforts to advance biomedical science.